868276463	868276463	CD	B-NP	O
|	|	NNP	I-NP	O
CH	CH	NNP	I-NP	O
|	|	VBD	B-VP	O
49907736	49907736	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0475555	0475555	CD	B-NP	O
|	|	CC	I-NP	O
10/4/2006	10/4/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
|	|	NN	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/4/2006	10/4/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/16/2006	3/16/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
WESTPHAL	WESTPHAL	NNP	B-NP	O
,	,	,	O	O
LANCE	LANCE	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
KH	KH	NN	B-NP	O
team	team	NN	I-NP	O
.	.	.	O	O

PRIMARY	PRIMARY	NN	B-NP	O
CARE	CARE	NN	I-NP	O
PHYSICIAN	PHYSICIAN	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Lucius	Lucius	NNP	I-NP	O
Rathmanner	Rathmanner	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
FOR	FOR	NNP	I-NP	O
ADMISSION	ADMISSION	NNP	I-NP	O
:	:	:	O	O
Asthma	Asthma	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

LIST	LIST	NN	B-NP	O
OF	OF	IN	B-PP	O
PROBLEMS	PROBLEMS	NNP	B-NP	O
DURING	DURING	NNP	I-NP	O
HOSPITALIZATION	HOSPITALIZATION	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Asthma	Asthma	NN	B-NP	O
exacerbation	exacerbation	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Diabetes	Diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Iron	Iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
38-year-old	38-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
type	type	NN	B-NP	O
II	II	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
iron	iron	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
anemia	anemia	NN	I-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Erta	Erta	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
3/9/06	3/9/06	CD	B-NP	O
complaining	complaining	NN	I-NP	O
of	of	IN	B-PP	O
worsening	worsen	VBG	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
tightness	tightness	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
three	three	CD	I-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
running	run	VBG	B-VP	O
out	out	RB	B-ADVP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
medications	medication	NNS	I-NP	O
approximately	approximately	RB	B-NP	O
two	two	CD	I-NP	O
weeks	week	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
ran	run	VBN	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
Advair	Advair	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Singulair	Singulair	NNP	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
fevers	fever	NNS	I-NP	O
or	or	CC	I-NP	O
chills	chill	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
or	or	CC	O	O
cough	cough	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
did	do	VBD	B-VP	O
report	report	VB	I-VP	O
some	some	DT	B-NP	O
increased	increase	VBN	I-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
several	several	JJ	I-NP	O
days	day	NNS	I-NP	O
and	and	CC	I-NP	O
admits	admit	NNS	I-NP	O
to	to	TO	B-PP	O
not	not	RB	B-VP	O
taking	take	VBG	I-VP	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
SWORTHLATE	SWORTHLATE	NNP	B-NP	O
UNIVERSITY	UNIVERSITY	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
urgernt	urgernt	NN	I-NP	O
care	care	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
84	84	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Room	Room	NNP	I-NP	O
for	for	IN	B-PP	O
admission	admission	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
received	receive	VBD	B-VP	O
nebulizer	nebulizer	NN	B-NP	O
treatments	treatment	NNS	I-NP	O
and	and	CC	O	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
x1	x1	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

HOME	HOME	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
takes	take	VBZ	B-VP	O
Advair	Advair	NNP	B-NP	O
500/50	500/50	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
nebulizers	nebulizer	NNS	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
,	,	,	O	O
iron	iron	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
850	850	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Prozac	Prozac	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Singulair	Singulair	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
multivitamin	multivitamin	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

REVIEW	REVIEW	NNP	B-NP	O
OF	OF	IN	B-PP	O
SYSTEMS	SYSTEMS	NNP	B-NP	O
:	:	:	O	O
Pertinent	Pertinent	NNP	B-NP	O
for	for	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
tightness	tightness	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Exam	Exam	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
pulse	pulse	NN	I-NP	O
was	be	VBD	B-VP	O
100	100	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
116/70	116/70	CD	I-NP	O
,	,	,	I-NP	O
respiratory	respiratory	JJ	I-NP	O
rate	rate	NN	I-NP	O
22	22	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
O2	O2	NN	B-NP	O
saturation	saturation	NN	I-NP	O
of	of	IN	B-PP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-NP	O
,	,	,	I-NP	O
alert	alert	JJ	I-NP	O
and	and	CC	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
and	and	CC	B-PP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
apparent	apparent	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
had	have	VBD	B-VP	O
scattered	scatter	VBN	I-VP	O
wheezing	wheeze	VBG	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
air	air	NN	I-NP	O
movement	movement	NN	I-NP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
with	with	IN	B-PP	O
normal	normal	JJ	B-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
S2	S2	NN	B-NP	B-protein
and	and	CC	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
had	have	VBD	B-VP	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bilateral	bilateral	JJ	I-NP	O
pitting	pitting	NN	I-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
erythema	erythema	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
bilateral	bilateral	JJ	I-NP	O
shins	shin	NNS	I-NP	O
.	.	.	O	O

PERTINENT	PERTINENT	NN	B-NP	O
LABORATORY	LABORATORY	NN	I-NP	O
DATA	DATA	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
10.6	10.6	CD	B-NP	O
and	and	CC	O	O
hematocrit	hematocrit	NN	B-NP	O
30	30	CD	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
cardiac	cardiac	JJ	I-NP	O
silhouette	silhouette	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
effusion	effusion	NN	B-NP	O
or	or	CC	I-NP	O
infiltrate	infiltrate	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PE	PE	NN	I-NP	O
protocol	protocol	NN	I-NP	O
CT	CT	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
suboptimal	suboptimal	JJ	I-NP	O
study	study	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
poor	poor	JJ	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
but	but	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
bilateral	bilateral	JJ	B-NP	O
ground	ground	NN	I-NP	O
glass	glass	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
and	and	CC	O	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
air	air	NN	B-NP	O
trapping	trapping	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
also	also	RB	B-ADVP	O
showed	show	VBD	B-VP	O
moderate	moderate	JJ	B-NP	O
hepatomegaly	hepatomegaly	NN	I-NP	O
.	.	.	O	O

PROCEDURES	PROCEDURES	NNS	B-NP	O
DURING	DURING	VBG	B-VP	O
HOSPITALIZATION	HOSPITALIZATION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PECT	PECT	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
performed	perform	VBN	B-VP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
38-year-old	38-year-old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
morbid	morbid	JJ	B-NP	O
obesity	obesity	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
asthma	asthma	NN	I-NP	O
exacerbation	exacerbation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
running	run	VBG	B-VP	O
out	out	RB	B-ADVP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
.	.	.	O	O

1	1	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
60	60	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
and	and	CC	O	O
remained	remain	VBD	B-VP	O
on	on	IN	B-PP	O
it	it	PRP	B-NP	O
for	for	IN	B-PP	O
approximately	approximately	RB	B-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
difficult	difficult	JJ	B-ADJP	O
to	to	TO	B-VP	O
taper	taper	VB	I-VP	O
her	her	PRP$	B-NP	O
prednisone	prednisone	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
oxygen	oxygen	NN	B-NP	O
desaturations	desaturation	NNS	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
oxygen	oxygen	NN	I-NP	O
desaturated	desaturate	VBD	B-VP	O
to	to	TO	B-PP	O
74-84	74-84	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
tapered	taper	VBN	I-VP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
on	on	IN	B-PP	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
of	of	IN	B-PP	O
prednisone	prednisone	NN	B-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
sent	send	VBN	I-VP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
Advair	Advair	NN	I-NP	O
and	and	CC	I-NP	O
Singulair	Singulair	NN	I-NP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
mentioned	mention	VBN	B-VP	O
above	above	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
PE	PE	NN	I-NP	B-protein
protocol	protocol	NN	I-NP	I-protein
CT	CT	NN	I-NP	I-protein
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
PE	PE	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
suboptimal	suboptimal	JJ	I-NP	O
study	study	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
ground	ground	NN	B-NP	O
glass	glass	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
.	.	.	O	O

Because	Because	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
desaturations	desaturation	NNS	B-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
concerned	concern	VBN	B-ADJP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
possibly	possibly	RB	B-ADVP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
atypical	atypical	JJ	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
given	give	VBN	B-VP	O
these	these	DT	B-NP	O
ground	ground	NN	I-NP	O
glass	glass	NN	I-NP	O
opacities	opacity	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	O	O
should	should	MD	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
five-day	five-day	JJ	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
tested	test	VBN	I-VP	O
for	for	IN	B-PP	O
HIV	HIV	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
BNP	BNP	NN	I-NP	O
to	to	TO	B-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
any	any	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
desaturations	desaturation	NNS	I-NP	O
.	.	.	O	O

BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
5	5	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
hepatitis	hepatitis	NN	B-NP	O
serologies	serology	NNS	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
hepatomegaly	hepatomegaly	RB	I-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
PECT	PECT	NN	B-NP	O
and	and	CC	O	O
these	these	DT	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

Influenza	Influenza	NN	B-NP	B-protein
swabs	swab	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
in	in	IN	B-PP	O
consult	consult	NN	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
team	team	NN	I-NP	O
and	and	CC	O	O
they	they	PRP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
requireed	require	VBD	B-VP	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
especially	especially	RB	B-ADVP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
and	and	CC	O	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
O2	O2	NN	I-NP	O
saturation	saturation	NN	I-NP	O
while	while	IN	B-SBAR	O
sleeping	sleeping	NN	B-NP	O
was	be	VBD	B-VP	O
84	84	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
highly	highly	RB	I-VP	O
suspected	suspect	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
component	component	NN	I-NP	O
of	of	IN	B-PP	O
sleep	sleep	NN	B-NP	O
apnea	apnea	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
set	set	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
sleep	sleep	NN	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	NNP	B-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
obtaining	obtain	VBG	I-VP	O
a	a	DT	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
function	function	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
were	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
FVC	FVC	NN	I-NP	O
of	of	IN	B-PP	O
51	51	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
FEV1	FEV1	NN	I-NP	O
of	of	IN	B-PP	O
49	49	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
FEV-FVC	FEV-FVC	JJ	I-NP	O
ratio	ratio	NN	I-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
total	total	JJ	I-NP	O
lung	lung	NN	I-NP	O
capacity	capacity	NN	I-NP	O
of	of	IN	B-PP	O
53	53	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
DLCO	DLCO	NN	I-NP	O
of	of	IN	B-PP	O
82	82	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
restrictive	restrictive	JJ	B-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
likely	likely	RB	B-ADJP	O
due	due	JJ	I-ADJP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
obesity	obesity	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
most	most	RBS	B-ADVP	O
likely	likely	RB	I-ADVP	O
has	have	VBZ	B-VP	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
spoke	speak	VBD	B-VP	O
with	with	IN	B-PP	O
her	her	PRP	B-NP	O
in	in	IN	B-PP	O
depth	depth	NN	B-NP	O
about	about	IN	B-PP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
losing	lose	VBG	B-VP	O
weight	weight	NN	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
improve	improve	VB	I-VP	O
her	her	PRP$	B-NP	O
respiratory	respiratory	JJ	I-NP	O
status	status	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
her	her	PRP$	B-NP	O
overall	overall	JJ	I-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
scheduled	schedule	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
sleep	sleep	NN	I-NP	O
study	study	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
pulmonologist	pulmonologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Dworaczyk	Dworaczyk	NNP	I-NP	O
Home	Home	NNP	I-NP	O
oxygen	oxygen	NN	I-NP	O
was	be	VBD	B-VP	O
set	set	VBN	I-VP	O
up	up	RP	B-PRT	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
for	for	IN	B-PP	O
her	her	PRP	B-NP	O
lower	low	JJR	I-NP	O
extremity	extremity	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
did	do	VBD	B-VP	O
improve	improve	VB	I-VP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
lipid	lipid	NN	I-NP	O
panel	panel	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
diabetes	diabetes	NN	I-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
experienced	experienced	JJ	B-NP	O
menorrhagia	menorrhagia	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
anemic	anemic	JJ	B-ADJP	O
so	so	IN	B-SBAR	O
the	the	DT	B-NP	O
aspirin	aspirin	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
started	start	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
menorrhagia	menorrhagia	NN	I-NP	O
is	be	VBZ	B-VP	O
addressed	address	VBN	I-VP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
iron	iron	NN	B-NP	O
deficient	deficient	JJ	B-ADJP	O
by	by	IN	B-PP	O
labs	lab	NNS	B-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
iron	iron	NN	B-NP	O
supplements	supplement	NNS	I-NP	O
three	three	CD	B-NP	O
times	time	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
complains	complain	VBZ	B-VP	O
of	of	IN	B-PP	O
heavy	heavy	JJ	B-NP	O
menstruation	menstruation	NN	I-NP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
uterine	uterine	JJ	B-NP	O
fibroids	fibroid	NNS	I-NP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
supposed	suppose	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
GYN	GYN	NN	B-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
but	but	CC	O	O
missed	miss	VBD	B-VP	O
her	her	PRP$	B-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
GYN	GYN	NN	B-NP	B-protein
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
home	home	NN	I-NP	O
medications	medication	NNS	I-NP	O
of	of	IN	B-PP	O
glyburide	glyburide	NN	B-NP	O
and	and	CC	I-NP	O
metformin	metformin	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
25	25	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
b.i.d.	b.i.d.	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
and	and	CC	I-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
hemoglobin	hemoglobin	NN	I-NP	B-protein
A1c	A1c	NN	I-NP	O
was	be	VBD	B-VP	O
7	7	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
resumed	resume	VBN	I-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Prophylaxis	Prophylaxis	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
received	receive	VBD	B-VP	O
Lovenox	Lovenox	NN	B-NP	O
and	and	CC	I-NP	O
Nexium	Nexium	NN	I-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-NP	O
,	,	,	I-NP	O
alert	alert	JJ	I-NP	O
,	,	,	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
desaturate	desaturate	VB	I-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
with	with	IN	B-PP	O
ambulation	ambulation	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
awake	awake	JJ	B-NP	O
,	,	,	I-NP	O
alert	alert	JJ	I-NP	O
,	,	,	I-NP	O
oriented	oriented	JJ	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
other	other	JJ	I-NP	O
pertinent	pertinent	JJ	I-NP	O
findings	finding	NNS	I-NP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

CONSULTANTS	CONSULTANTS	NNS	B-NP	O
DURING	DURING	VBG	B-VP	O
HOSPITALIZATION	HOSPITALIZATION	NN	B-NP	O
:	:	:	O	O
Pulmonary	Pulmonary	NNP	B-NP	O
was	be	VBD	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Koeppl	Koeppl	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
home	home	NN	B-ADVP	O
on	on	IN	B-PP	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	RB	B-ADVP	O
,	,	,	O	O
ferrous	ferrous	JJ	B-NP	O
sulfate	sulfate	NN	I-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Prozac	Prozac	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Advair	Advair	NNP	B-NP	O
Diskus	Diskus	NNP	I-NP	O
500/50	500/50	CD	I-NP	O
one	one	CD	I-NP	O
puff	puff	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Levaquin	Levaquin	NNP	B-NP	O
750	750	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
x1	x1	NN	B-NP	O
more	more	JJR	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
850	850	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Singulair	Singulair	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
prednisone	prednisone	NN	I-NP	O
taper	taper	NN	I-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
30	30	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	JJ	I-NP	O
x2	x2	NN	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
stopping	stop	VBG	B-VP	O
it	it	PRP	B-NP	O
and	and	CC	O	O
multivitamin	multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tablet	tablet	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

INSTRUCTIONS	INSTRUCTIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
encouraged	encourage	VBN	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
GYN	GYN	NN	B-NP	B-protein
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
regarding	regard	VBG	B-VP	O
her	her	PRP$	B-NP	O
uterine	uterine	JJ	I-NP	O
fibroids	fibroid	NNS	I-NP	O
and	and	CC	I-NP	O
menorrhagia	menorrhagia	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
follow-up	follow-up	JJ	I-NP	O
appointment	appointment	NN	I-NP	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
with	with	IN	B-PP	O
both	both	CC	O	O
her	her	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Saneaux	Saneaux	NNP	I-NP	O
in	in	IN	B-PP	O
February	February	NNP	B-NP	O
She	She	NNP	I-NP	O
met	meet	VBD	B-VP	O
with	with	IN	B-PP	O
Nutrition	Nutrition	NN	B-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
long	long	JJ	I-NP	O
conversation	conversation	NN	I-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
medical	medical	JJ	I-NP	O
team	team	NN	I-NP	O
regarding	regard	VBG	B-VP	O
weight	weight	NN	B-NP	O
loss	loss	NN	I-NP	O
strategies	strategy	NNS	I-NP	O
.	.	.	O	O

ADVANCE	ADVANCE	NN	B-NP	O
DIRECTIVES	DIRECTIVES	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-8182418	4-8182418	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ARCIA	ARCIA	NNP	B-NP	O
,	,	,	O	O
RICKIE	RICKIE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
CAUGHRAN	CAUGHRAN	NN	B-NP	O
,	,	,	O	O
BRIAN	BRIAN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
3358104	3358104	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/27/06	2/27/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/27/06	2/27/06	CD	B-NP	O

